Today we present an excellent discussion with Dr. Alan Krasner, Chief Medical Officer for Crinetics Pharmaceuticals. Dr. Krasner speaks to PWN about two very important drugs currently under development. Learn about what is coming, the timelines, potential new therapies, and approaches in acromegaly, Cushing's, and hyperinsulinism. These are exciting times in the field with a forward-thinking, creative group of scientists applying their knowledge and experience in pituitary and neuroendocrine science to develop new approaches and solutions for patients. This is a discussion you don't want to miss! Click on this link to learn more about Crinetics' clinical studies and how to participate.